Bharat Parenterals Limited (BPLPHARMA) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE365Y01019
Key metrics
- Market Cap
- ₹1,060 Cr
- P/E Ratio
- —
- EPS
- -50.02
- Book Value
- 452.09
- P/B Ratio
- 3.4
- ROE
- -2.63%
- ROCE
- -4.03%
- Debt / Equity
- 0.47
- Net Margin
- -2.37%
- Revenue Growth
- 1.48%
- Profit Growth
- 35.15%
- Dividend Yield
- 0.07%
- 52W High
- ₹1,593.95
- 52W Low
- ₹880.25
- Market Cap Band
- small cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Bharat Parenterals Limited
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing of general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
- Headquarters
- Vadodara, India
- Promoter Holding
- 79.74%
The full Bharat Parenterals Limited analysis
Create a free account to open the complete BPLPHARMA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.